Alliances & Global Licensing


iCo is opportunistically looking for available assets that have a previous clinical history.  iCo employs various drug delivery technologies, re-doses and/or reformulates existing products in order to enable optimal administration and gain additional intellectual property coverage for the asset. This strategy enables partners to maximize the value of their existing assets with minimal risk of cross use or cross pricing issues.


Copyright 2015 ICO Therapeutics | Disclaimer